Fate Therapeutics, Inc., CRISPR Therapeutics AG, M&T Bank Corp made yesterday's list of top gainers.

Leading equity indices in the US rose as Dow Jones gained 0.3% and closed at 34,000. S&P 500 ended the session at 4,151.32 after a 0.33% gain.

More data out yesterday as United States TIC Net Long-Term Transactions (Feb) released yesterday at 20:00 UTC with a figure of 71 billion, while the previous figure was 31.9 billion.

Have a look at yesterday's biggest gainers:

M&T Bank | Closed +7.78% at $125.66

The US bank closed at $125.66 after it made its largest daily jump of $9.07 (7.78%) since October 2022. The US commercial bank has shed 34.8% over the past six months. So far this year, it has been doing worse than the S&P by 21.79%. The company is currently trading with a market cap of $21.12 billion with an average daily volume of 2.43 million shares.

+7.67%: Enphase gains 7.67% within $214.78 to $229.23 daily range

Enphase Energy ended Friday's session at $208.9. yesterday started with an increase to $229.23, but dropped back and closed at $224.92. The company's market cap currently stands at $30.81 billion with an average daily trading volume of 3.71 million shares. So far this year, it has been under-performing the S&P by 19.54%.

+7.91%: CRISPR Therapeutics gains 7.91% within $50.5 to $55.36 daily range

An influx of buyers helped the gene-editing biotech company to end the session higher around $54.29, while establishing a $50.5 to $55.36 session range yesterday. Currently, the Swiss biotechnology company has a market capitalization of $4.27 billion with an average daily volume of 1.27 million shares. So far this year, it has been beating the Nasdaq by 21.29%.

+9.65%: Fate Therapeutics ended yesterday at $6.59, a 9.65% increase

After closing Friday at $6, Fate Therapeutics closed at $6.59 yesterday after climbing to $6.66 and dropping back down. Fate Therapeutics is currently trading with a market cap of $646.89 million with an average daily volume of 3.24 million shares. So far this year, it has been under-performing the Nasdaq by 51.94%.